Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews


EVG leverages more than 15 years of experience in biotech R&D and industry-proven substrate bonding and lithography solutions and expertise to support next-generation biotechnology device manufacturing. EV Group (EVG), a leading supplier of wafer bonding and lithography equipment for the MEMS, nanotechnology and semiconductor markets, announced that it is increasing its focus on bringing its high-volume manufacturing process solutions and services to the biotechnology and medical device market.

Read more ...

The Micro Total Analysis Systems (MicroTAS) conference celebrates 20 years of innovation in the field of miniaturized systems for applications in chemistry and the life sciences, at its annual meeting on 9 – 13 October 2016, at the Convention Center Dublin. 

Over the last two decades the field of MicroTAS, commonly referred to as Lab-on-a-Chip (LOC) systems, has seen tremendous growth. The conference now regularly attracts more than 1000 participants from around the world.

Read more ...

British surgeons hail successful procedure to remove membrane 100th of a millimetre thick from retina. British surgeons have successfully performed the world’s first robotic operation inside the eye, potentially revolutionising the way such conditions are treated. The procedure was carried out at John Radcliffe hospital in Oxford, where surgeons welcomed its success.

Read more ...

Researchers at the Department of Micro- and Nanosystems at KTH have developed a new way to simultaneously shape and surface treat plastic components. The new method can reduce the manufacturing cost of medical devices, such as diagnostic tools for various diseases.

When plastic components in various diagnostic tools, such as "labs-on-a-chip", are manufactured today, they are first shaped by injection molding, and thereafter surface treated to attain desirable surface properties.

Read more ...

The partnership between L'Oréal and UCF focuses specifically on the challenge that lies at the crossroads between two key technologies: cellular engineering and microfluidics. A functional, in vitro system has been developed, composed of human cells from four organs (muscle, heart, nerve and liver) which share a common serum-free media.

Read more ...

Cepheid announced that it has entered into a definitive agreement with Danaher under which Danaher will acquire all of the outstanding shares of Cepheid common stock for $53 per share in cash, or a total enterprise value of approximately $4 billion including indebtedness and net of acquired cash.

"Cepheid's vision has always been to enable as many people as possible to have access to powerful molecular diagnostic tests that provide critical information on a timely basis to guide treatment and patient management," said John Bishop, Cepheid's Chairman and Chief Executive Officer.

Read more ...

Upcoming Events

> LOAC World
(September 26 - September 28, San Diego, USA)

> MicroTAS 2016
(October 9 - October 13, Dublin, Ireland)

> 4th Advanced Technology Workshop on Microelectronics, Systems and Packaging for Medical Applications
(December 7 - December 8, France, Lyon)